How Can AI Token Usage Affect Healthcare Costs?
Organizations have been especially interested in using AI to streamline clinical workflows and reduce administrative burden for care teams. Applying AI to healthcare-specific tasks requires a significant amount of reasoning.
Prior authorizations, for example, can take up a majority of a physician’s time. Using AI to improve revenue operations (RevOps) provides significant financial ROI and will be a foundational AI use case across healthcare organizations, but it is a complex process that can’t be accomplished with a simple prompt.
READ MORE: Cleveland Clinic grounds tech change in reliability and scalability.
One approach organizations are taking is to build AI agents that read through a doctor’s note, gather the supporting material for a prior authorization, find the right codes for the procedure from the specific insurance company and then submit it. But any anomaly — such as if a doctor’s note is unclear and the AI agent has to do more intensive or redundant reasoning — means AI token costs can rise from cents to dollars for the process, turning ROI significantly negative.
From a physician’s standpoint, using an AI agent can save time, but from the finance department’s perspective, the organization doesn’t get the money back for that timesavings right away. The finance team has to reconcile the bill up front every month. So, if use cases are being created that have negative ROI potential, that requires proactive financial planning and real-time transparency linked fully to enterprise architecture, AI design and AI operations.
Rethinking AI Token Usage and Its Potential Costs
Standard AI usage can be relatively cheap and a significant competitive differentiator. When organizations start to rely on AI agents to retrieve information from an electronic health records system, cross-reference compliance standards or comb through payer guidelines, that involves more intensive token usage that’s not readily predictable.
In contrast, cloud usage is fairly deterministic. There’s auto-scaling, and when organizations rent X server, they know it’ll cost Y per month. From a billing perspective, there aren’t many surprises. AI model usage does not currently map out like that.
Organizations are also struggling to gain visibility into how their users are relying on generative AI services. Unless they have a gateway or some other method of observing usage, they just get one bill for all of it, whether or not users have had successful outcomes.
DISCOVER: Healthcare IT leaders seek a new north star in the age of AI.
Think of an organization that has 10 AI agents and five departments using them, with multiple workflows, but it can’t track which AI agent is providing what value for that cost. Assigning an ROI to a single workflow that uses an agent is difficult. Enterprises can receive a surprise bill with no visibility into what the usage was applied to or where the negative ROI is occurring.
AI is experiencing its own Jevons paradox — even though it’s getting cheaper to use, demand has increased, which means overall spending on it has skyrocketed as well. As costs decrease, people are finding more ways to use AI. Usage and visibility needs are rapidly exceeding organizations’ existing governance maturity and capabilities.
Improving Token Consumption Visibility and Budgeting
Healthcare organizations need not reinvent the wheel when it comes to managing token-based AI costs. There’s plenty from FinOps that can help to structure TokenOps, but like any enterprise architecture, it has to connect throughout the stack and become a key part of AI governance. It shouldn’t be siloed to one area of the organization.

